Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2003; 41:499-507, doi:10.1016/S0735-1097(02)02811-5
© 2003 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cominacini, L.
Right arrow Articles by Sawamura, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cominacini, L.
Right arrow Articles by Sawamura, T.

The platelet-endothelium interaction mediated by lectin-like oxidized low-density lipoprotein receptor-1 reduces the intracellular concentration of nitric oxide in endothelial cells

Luciano Cominacini, MD*,*, Anna Fratta Pasini, MD*, Ulisse Garbin, MD*, Antonio Pastorino, BSc*, Anna Rigoni, MD*, Cristina Nava, MD*, Anna Davoli, BSc*, Vincenzo Lo Cascio, MD* and Tatsuya Sawamura, MD{dagger}

* Department of Biomedical and Surgical Sciences of Verona University, Verona, Italy
{dagger} Department of Bioscience, National Cardiovascular Center Research Institute, Osaka, Japan



View larger version (30K):

[in a new window]
 
Figure 1 (A) Effect of different amounts of non-activated (T–) and thrombin-activated (T+) platelets on intracellular concentration of reactive oxygen species (ROS) and superoxide in bovine aortic endothelial cells (BAECs). The BAECs were preincubated with 2',7'-dichlorofluorescein diacetate and hydroethidine at 37°C for 20 min. Different amounts of (T–) and (T+) platelets (from 0 to 4.5 x 107/ml) were added to the BAEC medium for 10 min at 37°C. Results are expressed as mean fluorescence intensity (MFI) and are the means ± SD of experiments performed in triplicate on six separate occasions. ¶p < 0.01, *p < 0.001 vs. no addition of platelets (Control). (B) Time-course of superoxide formation induced by platelets activated with different amounts of thrombin in BAECs. The BAECs were preincubated with hydroethidine for 20 min. Platelets (3 x 107/ml) activated with different doses of thrombin (from 0.03 to 1 U/l) were added to the BAEC medium for the indicated times at 37°C. The BAECs and platelets alone were used as controls. Results are expressed as MFI and are the means ± SD of experiments performed in triplicate on six separate occasions. By two-way analysis of variance there was a significant effect for the thrombin concentrations (p < 0.001) and for the times of incubation (p < 0.001) with a significant concentrations/times interaction (p < 0.001) on superoxide generation. Post-analysis of variance Tukey test for multiple comparisons: ¶p < 0.01, *p < 0.001 vs. time 0.

 


View larger version (20K):

[in a new window]
 
Figure 2 Effect of vitamin C (Vit. C) and anti-LOX-1 monoclonal antibody (LOX-1 Ab) on platelet-induced variations of O2· concentration in bovine aortic endothelial cells (BAECs), Chinese hamster ovary-K1 (CHO) cells, and CHO-K1 cells stably expressing bovine LOX-1 (BLOX-1-CHO) cells. Vitamin C (5 µmol/l) and LOX-1 Ab (30 µg/ml) were preincubated with BAECs, BLOX-1-CHO, and CHO cells at 37° for 30 min. Thrombin-activated platelets (3 x 107/ml) were then added to the cell medium for 10 min at 37°C. Results are expressed as mean fluorescence intensity (MFI) and are the means ± SD of experiments performed in triplicate on six separate occasions. *p < 0.001 vs. platelets alone.

 


View larger version (19K):

[in a new window]
 
Figure 3 Effect of anti-LOX-1 monoclonal antibody (LOX-1 Ab), anti-CD41a antibody, annexin V, and immunoglobulin G (IgG) on platelet-induced variations of superoxide concentration in bovine aortic endothelial cells (BAECs). The LOX-1 Ab (30 µg/ml), anti-CD41a antibody (30 µg/ml) alone and mixed with LOX-1 Ab, annexin V (10 µmol/l), and IgG (30 µg/ml) were preincubated with BAECs for 30 min at 37°C. Thrombin-activated platelets (3 x 107/ml) were added to the cell medium for 10 min at 37°C. Results are expressed as percent variations of mean fluorescence intensity (MFI) and are the means ± SD of experiments performed in triplicate on six separate occasions. *p < 0.001 vs. platelets alone.

 


View larger version (29K):

[in a new window]
 
Figure 4 Effect of different amounts of non-activated (T–) and thrombin-activated (T+) platelets on basal and bradykinin-stimulated intracellular concentration of nitric oxide (NO) in bovine aortic endothelial cells (BAECs). The BAECs were preincubated with 10 µmol/l 4, 5 diaminofluorescein diacetate for 10 min at 37°C with or without 100 nmol/l bradykinin. Different amounts of (T–) and (T+) (from 0 to 4.5 x 107/ml) platelets were then added to the BAEC medium for 10 min at 37°C. Results are expressed as mean fluorescence intensity (MFI) and are the means ± SD of experiments performed in triplicate on six separate occasions. *p < 0.001, ¶p < 0.01 vs. no addition of platelets (Control).

 


View larger version (33K):

[in a new window]
 
Figure 5 Effect of vitamin C (Vit. C) and anti-LOX-1 monoclonal antibody (LOX-1 Ab) on platelet-induced variations of intracellular nitric oxide (NO) concentration in basal and bradykinin-stimulated bovine aortic endothelial cells (BAECs). The BAECs were preincubated with Vit. C (5 µmol/l) and anti-LOX-1 mAb (30 µg/ml) at 37°C for 30 min. Then the cells were incubated with 10 µmol/l DAF-2 DA at 37°C for 10 min with or without 100 nmol/l bradykinin. Thrombin-activated platelets (3.0 x 107/ml) were added to the BAEC medium for 10 min at 37°C. Results are expressed as mean fluorescence intensity (MFI) and are the means ± SD of experiments performed in triplicate on six separate occasions. ¶p < 0.01, *p < 0.001 vs. control; {dagger}p < 0.01, {ddagger}p < 0.001 vs. platelets.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement